| Literature DB >> 14721776 |
Renato Mastrangeli1, Silvia Donini, Christie A Kelton, Chaomei He, Alessandro Bressan, Ferdinando Milazzo, Veniero Ciolli, Francesco Borrelli, Fabrizio Martelli, Mauro Biffoni, Ottaviano Serlupi-Crescenzi, Serenella Serani, Emilia Micangeli, Nabil El Tayar, Rosa Vaccaro, Tindaro Renda, Romeo Lisciani, Mara Rossi, Ruben Papoian.
Abstract
The ARS Component B gene (EMBL ID: HSARS81S, AC: X99977) encodes a 9 kD non-glycosylated polypeptide (also known as SLURP-1, SwissProt/TrEMBL: P55000), a soluble member of the human Ly6/uPAR superfamily. ARS Component B gene mutations have been implicated in Mal de Meleda. In this study we show by immunohistochemistry that SLURP-1 (secreted Ly-6/uPAR related protein, the protein product of the ARS Component B gene) is localized to human skin, exocervix, gums, stomach and esophagus. In the epidermis, keratinocytes underlying the stratum corneum are highly positive for SLURP1 immunostaining and cultured keratinocytes secrete the expected 9 kD protein. Circulating SLURP1 is detected in human plasma and urine. In the mouse, expression is evident in skin, eye, whole lung, trachea, esophagus and stomach. Human ARS Component B mRNA expression is regulated by retinoic acid, epidermal growth factor and interferon-gamma. The tissue localization and the association with Mal de Meleda suggest that ARS Component B and its protein product SLURP1 are implicated in maintaining the physiological and structural integrity of the keratinocyte layers of the skin. Copyright John Libbey Eurotext 2003Entities:
Mesh:
Substances:
Year: 2003 PMID: 14721776
Source DB: PubMed Journal: Eur J Dermatol ISSN: 1167-1122 Impact factor: 3.328